Case ReportInitial Report of an Intradural Extramedullary Metastasis of a Pancreatic Neuroendocrine Tumor to the Cervical Spine: A Case Report and Review of the Literature
Introduction
Neuroendocrine tumors are a diverse group of malignancies defined as epithelial neoplasms with predominant neuroendocrine differentiation.1 These tumors arise from neuroendocrine cells distributed throughout the body; however, two thirds of these tumors are of pancreatic or gastrointestinal origin, with pancreatic or rectal origin entailing a worse prognosis.2 Although pancreatic neuroendocrine tumors (pNETs) have a relatively low incidence of 3 cases per million, they account for about 10% of malignant pancreatic cancers and have shown a steady increase in incidence over the past 3 decades.3,4
pNETs frequently metastasize to the liver, lymphatics, and less frequently to the peritoneum and lungs.5 Metastasis to the spine is exceedingly rare and can lead to spinal cord compression through extramedullary spread of tumor. Although the majority of reported cases of spinal cord compression from metastatic pNET lesions are characterized by extradural spread from a vertebral body lesion, only one other case of an intradural, extramedullary pNET metastasis has been reported to our knowledge in the upper thoracic spine.6 Here we report a 75-year-old male patient with a previous history of stage IV pNET treated with lanreotide injections who presented with an incidentally discovered intradural, extramedullary mass in the cervical spine. The patient was successfully managed with surgical resection of this solitary mass, which was found to be a pNET metastasis, and he was continued on lanreotide injections. To our knowledge, this is the first reported case of an intradural, extramedullary metastasis of a pNET to the upper cervical spine. We discuss the perioperative management as well as a brief review of the literature in regard to pNET spine metastasis.
Section snippets
Case Report
The patient was a 75-year-old man with a history of stage IV pNET with metastasis to the liver and lymph nodes that was originally diagnosed 2 years previously. The patient presented to our outpatient clinic after a positive emission topography (PET) scan, which was performed after precarinal, hilar, and cardiophrenic lymph nodes were noted to be increased in size on computed tomography (CT) of the chest, revealed a mass in the cervical spine. The patient had been successfully treated with
Discussion
The prevalence of spinal metastases has increased significantly in the past 2 decades. This is likely a function of both medical advancements improving the efficacy of cancer treatments and ultimately leading to longer survival times as well as improvements in imaging modalities leading to better detection of metastases.7 Furthermore, the improvement in survival time and surveillance has led to the discovery of metastases in nontraditional locations.
Metastatic spine disease is a frequently
Conclusions
As the efficacy of targeted treatment for pNETs has evolved, there has been a respective increase in prevalence of this disease seen in the population as patients are living longer. This has subsequently led to more unique presentations of systemic well-differentiated pNETs being reported. As the systemic spread of this disease corresponds with a more aggressive disease course, it is vital that patients diagnosed and treated for pNET be monitored for metastases, and when discovered, treated
References (35)
- et al.
The surgical treatment of metastatic disease of the spine
Radiother Oncol
(2000) - et al.
Part I: Spinal-cord neoplasms—intradural neoplasms
Lancet Oncol
(2007) - et al.
Extramedullary intradural spinal tumors: a pictorial review
Curr Probl Diagn Radiol
(2007) - et al.
Carcinoid tumor with intradural spinal metastases
J Comput Tomogr
(1988) - et al.
The pathologic classification of neuroendocrine tumors
Pancreas
(2010) - et al.
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
Clin Transl Oncol
(2019) - et al.
One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
J Clin Oncol
(2008) - et al.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
N Engl J Med
(2013) - et al.
Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study
Mol Clin Oncol
(2014) - et al.
C8-T1 radiculopathy due to an intradural extramedullary metastasis of a pancreatic neuroendocrine tumor
Pancreas
(2016)
Cancer undefeated
N Engl J Med
Metastatic disease of the spine
J Am Acad Orthop Surg
Metastases to the vertebral column
Cancer
Evaluation and treatment of spinal metastases: an overview
Neurosurg Focus
The appearance on MRI of vertebrae in acute compression of the spinal cord due to metastases
J Bone Jt Surg
Metastatic epidural spinal cord compression
Expert Rev Anticancer Ther
Intradural and extradural spinal metastases
Neurosurg Rev
Cited by (0)
Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- 4
Present address for Brian F. Saway: 96 Jonathan Lucas Street, Room: 301, MSC 606, Charleston, SC 29425